Novo Nordisk confident of amycretin obesity drug launch this decade
NOVO Nordisk’s head of development on Friday (Mar 8) told Reuters he was very comfortable the drugmaker would be able ...
Tag: amycretin
Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2024 Forbes 40under40. All Rights Reserved.